Cancer is accorded a special status in public debates, policy, clinical research and clinical practice. Relative to disease burden, cancer research receives a disproportionately high amount of funding compared to other diseases. In addition, some healthcare systems preferentially fund treatments for cancer. The Cancer Drugs Fund under the NHS, for example, created a funding mechanism dedicated solely to cancer drugs, which are treated more favourably when there are gaps in the evidence base supporting their cost-effectiveness. Meanwhile, the desire to detect cancer earlier via screening remains highly controversial—both in terms of its overall effectiveness and in terms of the best way to treat low-risk cancers. Such issues consistently place cancer under public scrutiny, creating dominant discourses that shape the very experience of the disease within one’s culture.
This conference brings together perspectives from clinical research, medical practice, philosophy, health economics and psychology to explore what makes cancer so special. Is the current amount of funding for cancer research and treatment justifiable? Are existing arrangements consistent with public perceptions of cancer, and what can the lived experience of actual patients, carers and clinicians teach us? Where is cancer research, treatment and policy going? This conference provides an opportunity to examine whether the special status of cancer is justifiable, and to explore the implications for the future of medicine.
Speakers: Karl Claxton (University of York), Peter Gøtzsche (Nordic Cochrane Centre), Shelley Hwang (Duke University), Stephen John (University of Cambridge), Christopher McCabe (Institute for Health Economics), Christian Munthe (University of Gothenburg), Mark Sheehan (University of Oxford), and Carla Willig (City, University of London).
Organisers Gabriele Badano (CRASSH Limits of the Numerical Project) Joseph Wu (HPS, Cambridge)
For administrative enquiries please contact Michelle Maciejewska.
This event is sponsored by the Limits of the Numerical research group at CRASSH, University of Cambridge, with generous support from the Independent Social Research Foundation (ISRF).
OffScrip Health
Cancer Together
Cancer Support Community
Morar Ervin
Frankly Speaking About Cancer
Cancer Care South East
National Cancer Institute
OffScrip Health
None
Stand Up To Cancer: The Podcast
Discovery South Africa
City of Hope
Johns Hopkins Kimmel Cancer Center
WVU Cancer Institute
BBC Radio 5 live
PodTechs Original
CancerCare
Memorial Sloan Kettering Cancer Center (MSKCC)
CancerCare
CancerCare
CancerCare
CancerCare
Oxford University
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
JT
CancerCare
CancerCare
CancerCare
Cancer Research Foundation
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
Dr. Jonathan Stegall
Cancer History Project
Ottawa Regional Cancer Foundation
Nasur Musasizi
The Irish Cancer Society
:Kristine :Earl:
CancerCare
CancerCare
CancerCare
CancerCare
CancerCare
UICC (Union for International Cancer Control)
HCG Oncology
Radio Manx Ltd / Isle of Man Anti-Cancer Association
CancerCare
Dr Penny Ward
None
University of Hawaiʻi Cancer Center
DImple Parmar
KY CancerLink
Leo Club of Subang Jaya Alumni
CancerCare
CancerCare
Enzo & Me Pediatric Cancer Foundation
Rosaria Kozar
CancerCare
CancerCare
Tara Stouder, Sarah Byrd
CancerCare
CancerCare
CancerCare
Cancer Pathways
UCTV
UCTV
CancerCare
The Unexpected Life Podcast
CancerCare
Memorial Sloan Kettering Cancer Center (MSKCC)
Beat Cancer
CancerCare
CancerCare
Leanne Pero
CancerCare
beyondfive
Providence
Joy
CancerCare
Archive
Cancer Survivor Guide
Tom
CancerCare